452 related articles for article (PubMed ID: 29374601)
1. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
2. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
3. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
Chang H; Xu Q; Li J; Li M; Zhang Z; Ma H; Yang X
Cell Death Dis; 2021 Jul; 12(8):725. PubMed ID: 34290225
[TBL] [Abstract][Full Text] [Related]
4. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
Xu CL; Lu XL; Yan XN; Wang HL; Chen SQ
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):134-8. PubMed ID: 22455747
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate Kinase M2 Knockdown Suppresses Migration, Invasion, and Epithelial-Mesenchymal Transition of Gastric Carcinoma via Hypoxia-Inducible Factor Alpha/B-Cell Lymphoma 6 Pathway.
Li N; Meng D; Xu Y; Gao L; Shen F; Tie X; Zhang Y; Yi Z; Shen W; Liu Z; Xu Z
Biomed Res Int; 2020; 2020():7467104. PubMed ID: 33376737
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
[TBL] [Abstract][Full Text] [Related]
8. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
9. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
Chen S; Youhong T; Tan Y; He Y; Ban Y; Cai J; Li X; Xiong W; Zeng Z; Li G; Yi M; Liu W; Xiang B
Carcinogenesis; 2020 Jul; 41(6):723-733. PubMed ID: 31665243
[TBL] [Abstract][Full Text] [Related]
10. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
Yang W; Xia Y; Cao Y; Zheng Y; Bu W; Zhang L; You MJ; Koh MY; Cote G; Aldape K; Li Y; Verma IM; Chiao PJ; Lu Z
Mol Cell; 2012 Dec; 48(5):771-84. PubMed ID: 23123196
[TBL] [Abstract][Full Text] [Related]
11. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.
Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J
Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489
[TBL] [Abstract][Full Text] [Related]
12. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
[TBL] [Abstract][Full Text] [Related]
13. PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation.
Azoitei N; Becher A; Steinestel K; Rouhi A; Diepold K; Genze F; Simmet T; Seufferlein T
Mol Cancer; 2016 Jan; 15():3. PubMed ID: 26739387
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
Yuan Q; Yu H; Chen J; Song X; Sun L
Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
[TBL] [Abstract][Full Text] [Related]
15. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
[TBL] [Abstract][Full Text] [Related]
16. P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway.
Yan L; He Z; Li W; Liu N; Gao S
Cell Cycle; 2021 Sep; 20(18):1875-1889. PubMed ID: 34382920
[TBL] [Abstract][Full Text] [Related]
17. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
18. PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer.
Wang C; Jiang J; Ji J; Cai Q; Chen X; Yu Y; Zhu Z; Zhang J
Sci Rep; 2017 Jun; 7(1):2886. PubMed ID: 28588255
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
Miao Y; Lu M; Yan Q; Li S; Feng Y
Oncol Res; 2016 Oct; 24(6):463-475. PubMed ID: 28281967
[TBL] [Abstract][Full Text] [Related]
20. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
Jia Y; Shi H; Cao Y; Feng W; Li M; Li X
Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]